Pfizer has sold a significant portion of its stake in German drugmaker BioNTech SE, a more than five years after the two ...

The financial markets responded immediately, with BioNTech shares declining as much as 5% in pre-market trading. This partnership has historically formed the cornerstone of BioNTech's commercial ...

You are reading the Morning Briefing newsletter. Get the news that prepares you for the day ahead, delivered to your inbox.

The future of German biotech firm CureVac will be determined on November 25, 2025, when shareholders decide whether to accept ...